The purpose of this clinical trial is to test the immune response and safety of a single dose of a Novavax investigational COVID-19 vaccine (NVX-CoV-2601) that uses SARS-CoV-2 Omicron antigen compared to the original Novavax vaccine.
Category: Past Studies
Immune Response to Shingles
The purpose of this study is to learn more about the immune response to shingles.
Shingrix Vaccination & Immune Response
A one-year study for people 60 years old or older, involving large volume blood draws, skin biopsies, and vaccination with FDA-approved Shingles vaccine.
Menstrual Cycle Study
The purpose of this study is to understand how immunity changes in the vagina over the course of the menstrual cycle. The study consists of 3 visits over the course of approximately a month.
Genital Herpes and Immune Memory Study
The purpose of this study is to learn more about the body’s immune response to genital herpes infections. To be eligible for the study you must be 18 years of age or older, test positive for HSV-2 antibodies by a blood test, and experience genital herpes outbreaks.
Immune Response Following Monkeypox (MPOX) Infection
This is a study of the immune response to monkeypox infection. Participants must be 18 years of age or older.
Monkeypox (MPOX) Vaccination & Immune Response
The purpose of this study is to learn more about the body’s immune response to monkeypox vaccination. The study may last for up to 3 months and involve 5-6 study visits.
Immunogenicity of Fractional Dose of the HPV Vaccines
The purpose of this research study is to determine if a fractional dose of the HPV vaccine produces a detectable immune response. The study will last for one year and involve 4 visits.
COVAIL COVID-19 Vaccine Trial
The purpose of this clinical trial is to test the safety and effectiveness of additional COVID-19 booster doses in people who have already received a primary COVID-19 vaccination series and booster dose. Participants will have completed a primary COVID-19 vaccination series (2 doses of Pfizer, 2 doses of Moderna, or 1 dose of Johnson & Johnson) and received a booster at least 16 weeks prior to joining the study.
“Mix ‘n Match” Booster COVID-19 Vaccine Trial
This is a Phase 1/2 COVID-19 vaccine booster trial. The purpose of this clinical trial is to test the safety and effectiveness of a booster dose of the Novavax sub-unit protein vaccine in people who have received an EUA vaccine series.